Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
0 hedge funds and large institutions have $0 invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 137 closing their positions.
100% less funds holding
Funds holding: 139 → 0 (-139)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $835M → $0 (-$835M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 137
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$180M |
| 2 |
BlackRock
New York
|
-$72.5M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$37.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.2M |
| 5 |
TAL
TIG Advisors LLC
New York
|
-$26.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$36K | -1,770 | Closed |
|
127
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$23K | -1,148 | Closed |
|
|
LC
128
Lindbrook Capital
Calabasas,
California
| – | -$21K | -1,051 | Closed |
|
|
CUAMC
129
China Universal Asset Management Company
Shanghai,
China
| – | -$9K | -448 | Closed |
|
|
S
130
SignatureFD
Atlanta,
Georgia
| – | -$8K | -402 | Closed |
|
131
Wells Fargo
San Francisco,
California
| – | -$7K | -352 | Closed |
|
132
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$5K | -246 | Closed |
|
|
QCG
133
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$5K | -245 | Closed |
|
|
AF
134
Allworth Financial
Folsom,
California
| – | -$3K | -170 | Closed |
|
135
Daiwa Securities Group
Tokyo,
Japan
| – | -$3K | -162 | Closed |
|
|
CG
136
Cutler Group
San Francisco,
California
| – | -$1K | -100 | Closed |
|
FMTX Hedge Fund Activity: Q4 2022 in Review
0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2022, worth a combined $0 — down 100% from $835M a quarter earlier.
Sellers outnumbered buyers: 137 funds closed out of FMTX and 0 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was RA Capital Management, exiting entirely with an estimated $180M sold.
- 0 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2022, down from 139 in Q3 2022.
- Funds reported $0 of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 137 closed out, a net change of -137 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was RA Capital Management, an estimated $180M sold.
Based on aggregated 13F filings for Q4 2022.